Aug. 15 at 2:03 PM
$VATE people are missing the boat on this name. while its true VATE’s remaining assets do not generate meaningful revenue or cash flow, they are still potentially quite valuable. CONX, a company controlled by Echostar, bought 75% of VATEs broadcasting business at a valuation of
$240 million. this business is marginally profitable at best, but it owns the largest amount of low power TV spectrum in the US. it has applied to the FCC to convert the spectrum to 5G broadcasting spectrum. if that happens, VATE’s remaining stake in the business could be worth A LOT! Perhaps
$20 per share or more on conservative spectrum valuations. CONX bought its stake at a conservative valuation for ”as is” low power tv spectrum. This valuation represents
$4.41 per share for VATEs 25% stake today. however the real prize is Medibeacon. the last public funding round from 2022(?) was at a
$400 million valuation, 3 years before Medibeacon got FDA approval.